| PRODUCT DESCRIPTION |
| (2S,5R)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID,DIPHENYLMETHYLESTER,4-OXIDE |
| FURAZOLIDONE (NOT FOR HUMAN/ MEDICAL USE, FOR ANIMAL USE ONLY) |
| FURAZOLIDONE (NOT FOR HUMAN/ MEDICAL USE, FOR ANIMAL USE ONLY) |
| EUSTAB LS-144-(BIS(1,2,2,6,6 PEN TAMETHYL4PIPERIDINYL)-[[3,5BIS(1,1-DIMETHYLETHYL)4HYDROXYPHENYL]METHYL]BUTYLMALONATE)CA |
| 2-CHLORO MANDELIC ACID |
| THIOPHENE-2-ETHYLAMINE |
| PMIC CHLORIDE |
| FCMIC CHLORIDE |
| LAMIVUDINE IP/USP (30 DRUMS X 25 KGS EACH = 750 KGS) |
| PMIC CHLORIDE |
| CMIC CHLORIDE [3-(2-CHLOROPHENYL)-5-METHYL ISOXAZOLE-CARBONYL CHLORIDE] |
| OXADIAZINAMINE |
| OXADIAZINAMINE |
| FURAZOLIDONE IP |
| 7-AMINO CEPHALOSPORAMIC ACID(7-ACA) |
| OXADIAZINAMINE |
| EFAVIRENZ |
| (R)-2-METHYL-CBS-OXAZABOROLIDINE SOLUTION |
| LEVOFLOXACIN HEMIHYDRATE USP |
| OFLOXACIN IP/USP |
| D 7 AMINOCEPHALOSPORANIC ACID (D-7ACA) (DEACETYL-7-AMINO CEPHALOSPORANIC ACID) |
| 2-((3AR,4S,6R,6AS)-6-AMINO-2,2-DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA(D)(1,3)DIOXL-4-YLOXY)ETHANOL L-TATARIC ACID |
| (1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPANAMINE HYDROCHLORIDE |
| LEVOFLOXACIN HEMIHYDRATE IP |
| RUBBER ACCELERATOR ETU (ETHYLENE THIOUREA) |
| (R) 2 METHYL CBS OXAZABOROLIDINE (0.5M) |
| A9251-5G ADENOSINE FREE BASE [ORGANIC CHEMICAL] |
| D 7 AMINOCEPHALOSPORANIC ACID (D-7ACA) (DEACETYL-7-AMINO CEPHALOSPORANIC ACID) |
| PURIFIED PLASMID DNA SAMPLE (FOR RESEARCH PURPOSE |
| DESACETYL-7-AMINO CEPHALOSPORANIC ACID (D-7-ACA) |
| XANTHAN GUM 200 MESH |
| D 7 AMINOCEPHALOSPORANIC ACID (D-7ACA) (DEACETYL-7-AMINO CEPHALOSPORANIC ACID) |
| LEVAMISOLE HYDROCHLORIDE IP/BP |
| LEVAMISOLE HYDROCHLORIDE IP/BP CHINA MAKE |
| LEVOFLOXACIN HEMIHYDRATE IP /IH |
| 1,2-DIAMINO-2-METHYL PROPANE |
| PROMEX MIT50 |
| 5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO (5,4-C) PYRIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE |
| 2-CHLOROTHIOXANTHONE 98% MIN |
| PROMEX CMT 14 NA |
| DISODIUM 5-RIBONUCLEOTIDE |